Ligands for the vitamin D endocrine system: Different shapes function as agonists and antagonists for genomic and rapid response receptors or as a ligand for the plasma vitamin D binding protein

Journal of Steroid Biochemistry and Molecular Biology

Volumn 76, Issue 1-5, 2001, Pages 49-59

  Norman, Anthony W ^a   Ishizuka, Seiichi ^b   Okamura, William H ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b TEIJIN LTD   (Japan)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CALCITRIOL RECEPTOR; CARBON; CELL NUCLEUS RECEPTOR; DRUG METABOLITE; LIGAND; MEMBRANE RECEPTOR; STEROID 11BETA MONOOXYGENASE; STEROID HORMONE; VITAMIN BINDING PROTEIN; VITAMIN D; VITAMIN D DERIVATIVE; VITAMIN D RECEPTOR;

BINDING SITE; CELL TYPE; CONFERENCE PAPER; CONFORMATIONAL TRANSITION; DRUG MECHANISM; ENDOCRINE SYSTEM; GENOME; HUMAN; LIGAND BINDING; NONHUMAN; PROTEIN SECONDARY STRUCTURE; PROTEIN TERTIARY STRUCTURE; RECEPTOR BINDING; STEREOSPECIFICITY; STRUCTURE ANALYSIS; TARGET ORGAN; TRANSCRIPTION REGULATION; VITAMIN METABOLISM;

ANIMALS; ENDOCRINE GLANDS; GENOME; HUMANS; LIGANDS; RECEPTORS, CALCITRIOL; VITAMIN D; VITAMIN D-BINDING PROTEIN;

EID: 0034987088     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(00)00145-X     Document Type: Conference Paper

References (55)

1. Vitamin D
2. Structure-function relationships in the vitamin D endocrine system
3. 3: A case study of transcaltachia (the rapid hormonal stimulation of intestinal calcium transport)
4. Vitamin D hydroxylases
5. Vitamin D binding protein
6. 3 and its analogs
7. The nuclear vitamin D receptor: Biological and molecular regulatory properties revealed
8. 3 in basal-lateral membranes of chick intestinal epithelium and relationship to transcaltachia
9. 3: Past, present, and future
10. Vitamin D
11. The vitamin D 25-hydroxylase
12. 3-1α-hydroxylase
13. The 25-hydroxyvitamin D 24-hydroxylase
14. Identification of the sterol- and actin-binding domains of plasma vitamin D binding protein (Gc-globulin)
15. 3-3β-(1,2-epoxypropyl)ether: An affinity labeling reagent for human vitamin D-binding protein
16. 3
17. 3 indicates that the 6-s-cis conformation is preferred for rapid nongenomic biological responses and that neither 6-s-cis nor 6-s-trans locked analogs are preferred for genomic biological responses
18. 3
19. Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains
20. Nuclear receptor ligands and ligand-binding domains
21. The crystal structure of the nuclear receptor for vitamin D bound to its naturalligand
22. Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid
23. A structural role for hormone in the thyroid hormone receptor
24. 3 are associated with enhanced activation of the vitamin D receptor
25. 3 analogues and their 20-epi homologues with the vitamin D receptor
26. 3 with two side chains: Interaction with its nuclear receptor and cellular actions
27. 3
28. 3 is independent of nuclear receptor binding
29. 3 prime NB4 leukemia cells for monocytic differentiation via nongenomic signaling pathways, involving calcium and calpain
30. 3 on the phosphoinositide metabolism in rat enterocytes
31. 3
32. 3
33. 3 on growth zone and resting zone chondrocyte membrane alkaline phosphatase and phospholipase-A2 specific activities
34. 3 and is involved in the rapid actions of the hormone
35. 3
36. 3
37. 3
38. 3-26,23-lactone analogs antagonize differentiation of human leukemia cells (HL-60 cells) but not of human acute promyelocytic leukemia cells (NB4 cells)
39. 3
40. 3-26,23S-lactone antagonizes the nuclear vitamin D receptor gby mediating a unique noncovalent conformational change
41. 3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): Receptor-mediated maturation to macrophage-like cells
42. 3 primes acute promyelocytic cells for TPA-induced monocytic differentiation through both PKC and tyrosine phosphorylation cascades
43. A dialogue on analogues: Newer vitamin D drugs for use in bone disease, psoriasis and cancer
44. Synthesis of vitamin D (calciferol)
45. The biological activity of nonsteroidal vitamin D hormone analogs lacking both the C- and D-rings
46. 3
47. 3-regulated expression of the eukaryotic genome
48. 3 metabolite for both normal bone integrity and healing of tibial fracture in chicks
49. 3 production by cultured alveolar macrophages from normal human donors and from patients with pulmonary sarcoidosis
50. 3
51. Origin of the use of calcipotriol in psoriasis treatment
52. 3 analogues: A novel class of potent regulators of cell growth and immune responses
53. Immunomodulatory effects of vitamin D analog KH1060 on an experimental skin transplantation model
54. 3 (as a 6-s-cis analog) stimulates nongenomic but not genomic biological responses
55. 3 of whole cell chloride currents in osteoblastic ROS 17/2.8 cells: A structure-function study